1. Home
  2. PAAS vs RMD Comparison

PAAS vs RMD Comparison

Compare PAAS & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pan American Silver Corp.

PAAS

Pan American Silver Corp.

HOLD

Current Price

$51.23

Market Cap

28.3B

Sector

N/A

ML Signal

HOLD

Logo ResMed Inc.

RMD

ResMed Inc.

HOLD

Current Price

$220.06

Market Cap

33.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAAS
RMD
Founded
1994
1989
Country
Canada
United States
Employees
9348
10600
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3B
33.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PAAS
RMD
Price
$51.23
$220.06
Analyst Decision
Buy
Buy
Analyst Count
4
10
Target Price
$57.75
$293.70
AVG Volume (30 Days)
6.9M
905.2K
Earning Date
05-06-2026
04-22-2026
Dividend Yield
1.09%
1.08%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$35.89
$10.58
Revenue Next Year
N/A
$7.38
P/E Ratio
$33.54
$25.61
Revenue Growth
N/A
N/A
52 Week Low
$20.55
$199.92
52 Week High
$69.99
$293.81

Technical Indicators

Market Signals
Indicator
PAAS
RMD
Relative Strength Index (RSI) 41.25 25.68
Support Level $44.68 N/A
Resistance Level $55.85 $260.21
Average True Range (ATR) 2.74 5.21
MACD -0.70 -1.21
Stochastic Oscillator 28.73 1.59

Price Performance

Historical Comparison
PAAS
RMD

About PAAS Pan American Silver Corp.

Pan American Silver Corp is a mining company principally engaged in the operation and development of, and exploration for, silver and gold-producing properties and assets. The company's principal products are silver and gold, although it also produces and sells zinc, lead, and copper. Its operating mines comprise La Colorada, Dolores, Huaron, Morococha, Shahuindo, La Arena, Timmins West, Bell Creek, Manantial Espejo, and San Vicente mines.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.

Share on Social Networks: